Drug application

RISPERIDONE (RISPERIDONE)

Drugs@FDA ANDA 076908 · CHARTWELL RX

Key facts

Drug name RISPERIDONE
Active ingredients RISPERIDONE
Application type ANDA
Application number 076908
Company CHARTWELL RX
Dosage forms TABLET, ORALLY DISINTEGRATING, ORAL
Strength 0.5MG
Marketing status Discontinued
Reference listed drug No
Latest submission status date Mar 12, 2012

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications